Citius Pharmaceuticals (CTXR) Deferred Taxes (2022 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Deferred Taxes came in at -$231210.0 in Q1 2026, down 187.5% YoY from $264240.0 in Q1 2025, and down 187.5% on a QoQ basis from $264240.0 in Q4 2025.
Citius Pharmaceuticals (CTXR) Deferred Taxes (2022 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 5 years of Deferred Taxes data on file, last reported at -$231210.0 in Q1 2026.
- Quarterly Deferred Taxes fell 187.5% year-over-year to -$231210.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $561510.0 (down 31.23% YoY) and the FY2025 annual result came in at $1.1 million, up 83.5% from the prior year.
- Deferred Taxes slipped to -$231210.0 in Q1 2026, from $264240.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $264240.0 in Q4 2024 to a low of -$231210.0 in Q1 2026.
- A 5-year average of $160142.1 and a median of $144000.0 in 2022 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2024 — Deferred Taxes surged 83.5% — and 2026, when it slumped 187.5%.
- Tracing CTXR's Deferred Taxes over 5 years: stood at $144000.0 in 2022, then changed by 0.0% to $144000.0 in 2023, then surged by 83.5% to $264240.0 in 2024, then changed by 0.0% to $264240.0 in 2025, then tumbled by 187.5% to -$231210.0 in 2026.
- The last three Deferred Taxes figures came in at -$231210.0 (Q1 2026), $264240.0 (Q4 2025), and $264240.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Citius Pharmaceuticals | 15.82 Mn | 15.82 Mn | 1.00 Mn | -107,347.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -231,210.00 |
| Dec 31, 2025 | 264,240.00 |
| Sep 30, 2025 | 264,240.00 |
| Jun 30, 2025 | 264,240.00 |
| Mar 31, 2025 | 264,240.00 |
| Dec 31, 2024 | 264,240.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Mar 31, 2024 | 144,000.00 |
| Dec 31, 2023 | 144,000.00 |
| Sep 30, 2023 | 144,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 144,000.00 |
| Dec 31, 2022 | 144,000.00 |